COMP <GO>
CBRS vs NVDA // 10Y YIELD & FRED MACRO BETA
Cerebras Systems Inc. (NASDAQ) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: CBRS 5
— NVDA 10
▲ 10Y YIELD & FRED MACRO BETA LEADER: NVDA
LAST: $109.18 (-5.19%) • MKT CAP: $27.36B
macro-sensitivity
1.34
LAST: $204.64 (-4.22%) • MKT CAP: $4.93T
macro-sensitivity
2.04
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CBRS VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CBRS | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.00% | 74.67% | -12.67 | NVDA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 58.30% | 65.06% | -6.76 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.0x | 23.2x | -9.21 | CBRS | /valuation <GO> |
| Free Cash Flow Yield | 3.99% | 2.58% | +1.41 | CBRS | /fcf-yield <GO> |
| Operating Margin | 21.10% | 65.21% | -44.11 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 16.40% | 63.66% | -47.26 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | 23.10% | 83.38% | -60.28 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.02% | -0.02 | NVDA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 22.36 | 19.52 | +2.84 | CBRS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | CBRS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 8.10% | 9.01% | -0.91 | CBRS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.8 | 35.1 | -5.31 | NVDA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.34 | 2.04 | -0.70 | NVDA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.2x | 17.0x | +1.18 | NVDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $27.36B | $4.93T | -$4.90T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CBRS REV | NVDA REV | CBRS GROSS % | NVDA GROSS % | CBRS FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $0 | $130.50B | — | 75.0% | $0 | $60.85B |
| FY 2024 | — | $60.92B | — | 72.7% | — | $27.02B |
| FY 2023 | — | $26.97B | — | 56.9% | — | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CBRS // BETA 1.34
NVDA // BETA 2.04